More recent success stories include the type 2 diabetes drug Byetta, which is based on a peptide from the Gila monster, a venomous lizard, and the pain medication Prialt, based on a toxin from cone snails. As is often the case, those discoveries owed much to serendipity. Researchers are now hoping systematic analysis of novel venoms will bring more success.
by Celia Henry Arnaud |
October 27, 2014